Navigation Links
Jennerex Announces First Patient Treated in Phase 2 Clinical Trial of Intravenous Delivery JX-594 In Patients with Advanced Liver Cancer
Date:7/25/2012

eered to enhance this cancer-selectivity by inactivating its thymidine kinase (TK) gene, thus making it dependent on the cellular TK expressed at persistently high levels in cancer cells. To enhance product efficacy, JX-594 is also engineered to express the immunogenic GM-CSF protein. GM-CSF complements the cancer cell lysis of the product candidate, leading to a cascade of events resulting in tumor necrosis, tumor vasculature shutdown and sustained anti-tumoral immune attack.

Hepatocellular Carcinoma: A Global Unmet Need

Hepatocellular carcinoma is the fifth most common cancer worldwide and the third leading cause of cancer death, with over 600,000 new cases diagnosed annually resulting in more than 90 percent mortality.  The annual incidence rate in the U.S., Europe, Japan and China are estimated to be 20,000, 55,000, 40,000 and 350,000 patients, respectively.

About Jennerex's Partners for JX-594

Transgene (NYSE Euronext Paris: FR0005175080), a bio-pharmaceutical company specialized in the development of immunotherapeutic products, holds an exclusive license to develop and commercialize JX-594 in Europe and neighboring countries. Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, holds an exclusive license to develop and commercialize JX-594 in South Korea, and Lee's Pharmaceutical Ltd. holds an exclusive license to develop and commercialize JX-594 in China.

Transgene, a member of the Institut Merieux Group, is a publicly traded French biopharmaceutical company dedicated to the development of therapeutic vaccines and immunotherapeutic products in oncology and infectious diseases, and has five compounds in clinical development: TG4010 and JX-594 (TG6006) having completed initial phase II trials, TG4001 in phase IIb trial, TG4040 in phase II trial and TG4023 in phase I trial. Transgene has concluded strategic agreements for the
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Jennerex Appoints Dr. Laurent Fischer as President and Chief Executive Officer
2. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
3. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
4. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
5. Misonix Announces New Distribution Agreement For Panama
6. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
9. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
10. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
11. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... July 14, 2014 Decision Resources Group ... positively influence perceptions of emerging drugs for both ... 100 oncologists (50 medical oncologists and 50 hematological ... of managed care organizations (MCOs), reveals that despite ... the majority of payers say this designation will ...
(Date:7/14/2014)... 14, 2014  More than any other generation, Millennials born ... computers -- but their eyes don,t. These mobile devices demand ... and the eye has not evolved to cope with them. ... can do comfortably often results in tired eyes, focusing problems, ... Eye Strain. Now ZEISS has invented a new type of ...
(Date:7/14/2014)... 2014  Diomics, Inc., provider of X-Swab™, a ... United States Patent and Trademark Office has issued ... biologic sample collection materials, devices made from them, ... diagnostics. The primary method of ... of DNA from a number of commercially-available swabs ...
Breaking Medicine Technology:Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing 2Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing 3New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives 2New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives 3Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics 2
... Article Underscoring Importance of PGD Technique and Method ... fertility experts, who pioneered the development of Preimplantation ... practices and explaining what errors can be made ... edition of Fertility and Sterility, details ...
... Improve Diagnosis for Children with Cornelia deLange Syndrome-PHILADELPHIA, ... studying a rare genetic disease discovered that a ... keeping chromosomes together also plays an important role ... is disrupted in the multisystem genetic disease Cornelia ...
Cached Medicine Technology:Newly Published Article Details How PGS Techniques Directly Effect Successful Pregnancy Outcomes 2In Rare Disorder, a Familiar Protein Disrupts Gene Function 2In Rare Disorder, a Familiar Protein Disrupts Gene Function 3In Rare Disorder, a Familiar Protein Disrupts Gene Function 4
(Date:7/14/2014)... T.E.N., an information technology and security ... nominations will be accepted now through Sept. 12, ... North America Awards. , Awards include the ... executives who have made a positive impact on ... compliance, privacy and information security; and the ISE® ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 The ... reach USD 4,285.1 million by 2020 growing at ... study by Grand View Research, Inc. Steady increase ... for bioinformatics R&D programs designed for sequencing genomes ... of clinical studies in pharmacogenomics and pharmacokinetics for ...
(Date:7/14/2014)... Since 1986, the Sheraton Premiere at Tysons Corner ... skyline and a staple within the community. With ... “Tysons”, the iconic hotel will now be identified as ... becoming its own municipality, the opening of four Metro ... an evolution of great magnitude and the Sheraton Tysons ...
(Date:7/14/2014)... SC (PRWEB) July 14, 2014 Many diet ... a study by the School of Public Health at ... vegetable consumption had a near-zero effect on weight loss. Now ... be combine with some form of portion control ... method of monitoring portions and controlling how much is consumed, ...
(Date:7/14/2014)... “You've probably heard the expression, 'You ... mean?” This question was posed in an article by ... Medical Group’s blog regarding how people should select what ... . , According to the article, individuals who consume ... a high risk of dehydration and consequent negative health ...
Breaking Medicine News(10 mins):Health News:T.E.N. Accepting Nominations for the 2014 Information Security Executive® North America Awards 2Health News:T.E.N. Accepting Nominations for the 2014 Information Security Executive® North America Awards 3Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 2Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 3Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 4Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 5Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 6Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 2Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 3Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 4Health News:Increase Vegetable Consumption Has Zero Effect on Weight Loss – Portion Control is Recommended by Experts 2Health News:Increase Vegetable Consumption Has Zero Effect on Weight Loss – Portion Control is Recommended by Experts 3Health News:Drink With Your Mental Health in Mind, Advises an Article by Mental Health America Featured by Western Washington Medical Group 2
... Steven Reinberg HealthDay Reporter , SATURDAY, April 2 ... for atherosclerosis, which can increase the risk of a heart ... were associated with about a 5 percent increase in the ... carotid artery, which carries blood to the brain, the researchers ...
... the risk of developing Alzheimer,s has uncovered five new genes ... Professor Julie Williams from Cardiff ... an additional five new genes bringing the total number ... ten. "What we did in this study is ...
... Discovery, the newest journal of the American Association for ... Meeting 2011, held April 2-6, showed how evaluating the ... better target therapy in breast cancer. Researchers ... the level of macrophages and CD8+ T-cells, two key ...
... ORLANDO, Fla. Using new genetic information, scientists have ... longer telomeres and reduced risk of bladder cancer, according ... 2011, held April 2-6, and simultaneously published in Cancer ... Cancer Research. Jian Gu, Ph.D., assistant professor ...
... use has been linked to thicker arteries, possibly contributing to ... of twin veterans. The data is being presented Tuesday, April ... Orleans. Depression can heighten the risk for heart disease, ... is separate and independent from depression itself, says first author ...
... continuing their work on the Biomarker-integrated Approaches of Targeted Therapy ... the BATTLE trial and presented updated results at the ... John Heymach, M.D., Ph.D., associate professor of thoracic, ... MD Anderson Cancer Center, said this update details the "discovery ...
Cached Medicine News:Health News:Study Hints at Link Between Antidepressants and Heart Trouble 2Health News:Study Hints at Link Between Antidepressants and Heart Trouble 3Health News:Understanding Alzheimer’s: Genetic search uncovers five new genes 2Health News:Understanding Alzheimer’s: Genetic search uncovers five new genes 3Health News:Immune system may guide chemotherapy for breast cancer 2Health News:Genetic variation linked to longer telomeres and lower risk of bladder cancer 2Health News:Antidepressants linked to thicker arteries 2Health News:BATTLE researchers identify new biomarkers for EGFR inhibition 2
... an enterprise visibility solution that allows ... effectiveness, and increase patient satisfaction. ... systems and geospatial visual technologies with ... a real time patient care model ...
MONOJECT SUPRA/HONE Blood Collection Needles - Thin Wall...
... are preominantly used for routine blood collection. ... of the needle protective cap simplifies visual ... example, yellow symbolises the needle dimension 20 ... mm) and black 22 G (0.70 mm). ...
ScanGel® Centrifuge...
Medicine Products: